[REGN] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
02-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 4.07%
YoY- -23.40%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 3,720,700 3,362,700 2,936,200 3,452,800 2,294,000 2,048,400 1,663,496 14.34%
PBT 1,493,000 1,110,800 1,509,800 1,816,600 998,300 768,500 635,861 15.27%
Tax 152,400 103,000 194,100 184,400 156,200 98,900 41,206 24.33%
NP 1,340,600 1,007,800 1,315,700 1,632,200 842,100 669,600 594,655 14.49%
Tax Rate -10.21% -9.27% -12.86% -10.15% -15.65% -12.87% -6.48% -
Total Cost 2,380,100 2,354,900 1,620,500 1,820,600 1,451,900 1,378,800 1,068,841 14.25%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 36.03 29.97 44.81 47.27 36.71 32.69 35.75 0.12%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 12.40 9.48 11.66 15.37 7.98 6.12 5.51 14.46%
EPS Diluted 11.54 8.89 11.66 14.33 7.39 5.86 5.17 14.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.